Enhanced Apoptosis Predicts Shortened Survival in Non-Small Cell Lung Carcinoma

Cancer Research

Volumn 55, Issue 23, 1995, Pages 5595-5602

  Törmänen, Ulla ^a   Eerola, Anna Kaisa ^a   Rainio, Pekka ^d   Vähäkangas, Kirsi ^b   Soini, Ylermi ^a   Sormunen, Raija ^a   Bloigu, Risto ^c   Lehto, Veli Pekka ^a   Pääkkö, Paavo ^a  

^a Departments of Pathology ^*  (Finland)

^b Biocenter   (Finland)

^c Applied Mathematics and Statistics ^*  (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA; ONCOPROTEIN; PROTEIN P53;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR NECROSIS;

AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN P53; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL;

EID: 0028787781     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Krajewski, S., Tanaka, S., Takayama, S., Schibier, M. J., Fenton, W., and Reed, J. C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res., 53: 4701–4714, 1993.
2. Reed, J. C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1–6, 1994.
3. Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., and Croce, C. M. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14: 18) chromosome translocation. Science (Wash. DC), 226: 1097–1099, 1984.
4. Bakhshi, A., Jensen, J. P., Goldman, P., Wright, J. J., Wesley McBride, O., Epstein, A. L., and Korsmeyer, S. J. Cloning the chromosomal breakpoint of t( 14: 18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on chromosome 18. Cell, 41: 899–906, 1985.
5. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855–4878, 1994.
6. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345–347, 1991.
7. Yonish-Rouach, E., Grunwald, D., Wilder, S., Kimchi, A., May, E., Lawrence, J-J., May, P., and Oren, M. p55-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol., 13: 1415–1423, 1993.
8. Shaw, P., Bowey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in human colon tumor-derived cell line. Proc. Natl. Acad. Sei. USA, 257: 212–214, 1992.
9. Ryan, J. J., Danish, R., Gottlieb, C. A., and Clarke, M. F. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell. Biol., 13: 711–719, 1993.
10. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of the human box gene. Cell, 80: 293–299, 1995.
11. Xia, F., Wang, X., Wang, Y-H., Tsang, N-M., Yandell, D. W., Kelsey, K. T., and Liber, H. L. Altered p53 status correlates with differences in sensitivity to radiation-induced mutation and apoptosis in two closely related human lymphoblast lines. Cancer Res., 55: 12–15, 1995.
12. Ebina, M., Steinberg, S. M., Mulshine, J. L., and Linnoila, R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54: 2496–2503, 1994.
13. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828–4831, 1992.
14. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., and Shirakusa, T. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer. J. Natl. Cancer Inst., 85: 2018–2023, 1993.
15. Harpole, D. H., Hemdon, J. E., Wolfe, W. G., Iglehart, J. D., and Marks, J. R. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. Cancer Res., 55: 51–56, 1995.
16. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., and Mason, D. Y. Bcl-2 protein in non-small cell lung carcinoma. N. Engl. J. Med., 329: 690–694, 1993.
17. World Health Organization. Histological Typing of Lung Tumours. International Classification of Tumours. No 1. Geneva: World Health Organization, 1981.
18. Hsu, S-M., Raine, L., and Fanger, H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem., 29: 577–580, 1981.
19. Soini, Y., Kamel, D., Nuorva, K., Lane, D. P., Vähäkangas, K., and Pääkkö, P. Low p53 protein expression in salivary gland tumours compared with lung carcinomas. Virchows Arch. A Pathol. Anat. Hist., 421: 415–420, 1992.
20. Lipponen, P. K., and Aaltomaa, S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J. Pathol., 173: 333–339, 1994.
21. McLaren, R., Kuzu, I., Dunnill, M., Harris, A., Lane, D., and Gatter, K. C. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer, 66: 735–738, 1992.
22. Kerr, J. F. R., Wyllie, A. H., and Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26: 239–257, 1972.
23. Walker, N. I., Harmon, B. V., Gobé, G. C., and Kerr, J. F. R. Patterns of cell death. Methods Achiev. Exp. Pathol., 13: 18–54, 1988.
24. Bursch, W., Paffe, S., Putz, B., Barthel, G., and Schulte-Hermann, R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis (Lond.), 5: 847–853, 1990.
25. Ray, R., Tahan, S. R., Andrews, C., and Goldman, H. Stromal tumors of the stomach: prognostic value of the PCNA index. Mod. Pathol., 7: 26–30, 1994.
26. Oda, Y., Hashimoto, H., Takeshita, S., and Tsuneyoshi, M. The prognostic value of immunohistochemical staining for proliferating cell nuclear antigen in synovial sarcoma. Cancer (Phila.), 72: 478–485, 1993.
27. Bardeesy, N., Beckwith, J. B., and Pelletier, J. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res., 55: 215–219, 1995.
28. Poller, D. N., Roberts, E. C., Bell, J. A., Eiston, C. W., Blarney, R. W., and Ellis, I. O. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum. Pathol., 24: 463–468, 1993.
29. Chopp, M., Li, Y., Zhang, Z. G., and Freytag, S. O. p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem. Biophys. Res. Commun., 182: 1201–1207, 1992.
30. Joensuu, H., Pylkkänen, L., and Toikkanen, S. Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol., 145: 1191–1198, 1994.